Caliper Life Sciences, Illumina, First Genetic Trust, Orchid BioSciences, BioMerieux, Epoch Biosciences, NIEHS, Third Wave Technologies, Cybergenetics, Marligen Biosciences, Qiagen, ParAllele BioScience | GenomeWeb

Caliper Acquires Cell-Based Screening Tech from Amphora

Caliper Life Sciences will acquire from Amphora certain cell-based screening assays, the companies said last week. Caliper will use the technology to develop a new calcium-flux assay for G-protein-coupled receptor drug targets.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.